TraceScribe
Feasibility
HFrEF Phase 3
...
FEASIBILITY
Trial Feasibility Workbench
Heart failure, reduced EF (NYHA II-IV)
2 arms 1:1
Global,
60
sites
Target
1,000
randomized
One control panel, four live consequences